Yali Cao

Adjuvant Capecitabine With Docetaxel and Cyclophosphamide Plus Epirubicin for Triple-Negative Breast Cancer (CBCSG010): An Open-Label, Randomized, Multicenter, Phase III Trial

Junjie Li, Ke‐Da Yu, Da Pang et al. · Journal of Clinical Oncology · 2020 · 106 citations · Full text

Medicine, Oncology, Pharmacology +17

Distribution of mammographic density and its influential factors among Chinese women

Ye Yan, Peishan Wang, Peifang Liu et al. · International Journal of Epidemiology · 2014 · 88 citations · Full text

Medicine, Preventive Medicine, Radiology +16

GSKJ4, an H3K27me3 demethylase inhibitor, effectively suppresses the breast cancer stem cells

Ningning Yan, Liang Xu, Xiaobo Wu et al. · Experimental Cell Research · 2017 · 88 citations

Life Sciences, Molecular Biology, Oncology +14

Serum miR-182 and miR-331-3p as diagnostic and prognostic markers in patients with hepatocellular carcinoma

Feihu Chu, Yali Cao, Jianguo Shao · Tumor Biology · 2015 · 83 citations

Medicine, Cancer Biology, Oncology +17

miR-34a expression in human breast cancer is associated with drug resistance

Zhihua Li, Xueling Weng, Qiuyun Xiong et al. · Oncotarget · 2017 · 53 citations · Full text

Life Sciences, Molecular Biology, Oncology +15